Immunoprecise announces ai-driven breakthrough in universal dengue vaccine discovery

Austin, texas--(business wire)---- $amd #ai--immunoprecise antibodies ltd. (ipa) (nasdaq:ipa) a leader in ai-driven biotherapeutics, announces discovery of a highly conserved epitope across all four dengue virus serotypes using its proprietary lensai™ platform powered by their patented hyft® technology. this discovery, made using several proprietary hyft-based analyses, identifies a part of the virus (an epitope) that has remained unmutated across all four known virus serotypes, therefore potentially allowi.
AMD Ratings Summary
AMD Quant Ranking